Astrocytoma Drug Market Size

Market Size in USD Bn

CAGR8.4%

Study Period	2025-2032
Base Year of Estimation	2024
CAGR	8.4%
Market Concentration	Medium
Major Players	F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., Bristol Myers Squibb, AbbVie Inc. and Among Others

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Astrocytoma Drug Market Analysis

The astrocytoma drug market is estimated to be valued at USD 1.76 billion in 2025 and is expected to reach USD 3.10 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2032. Increasing prevalence of brain cancer worldwide along with rising healthcare expenditure is positively impacting the growth of this market. However, factors such as high cost of drugs and limited treatment options continue to remain major challenges for the market.